Conduit Pharmaceuticals Inc (NASDAQ: CDT) – Suitable For Long Term Buy?
Currently, there are 4.71M common shares owned by the public and among those 3.31M shares have been available to trade. Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, […]
